*By Carlo Versano*
The world's largest beverage maker is reportedly eyeing the red-hot cannabis market, according to a [report] (https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528).
Coca-Cola is in "serious talks" with Aurora Cannabis to develop cannabidiol-infused beverages, according to BNN Bloomberg.
A deal on that scale would likely dwarf agreements made by Corona-maker Constellation Brands and Molson Coors, both of which have partnered with Canadian cannabis companies to add CBD, the non-psychoactive ingredient in cannabis that can be used to treat pain or anxiety, to drinks like coffee, soda, and beer, and would represent a "mainstreaming" of pot products in the eyes of Wall Street.
For Coke, getting into the weed market would be both capturing a trend and a diversification play. Soda sales have been down as younger consumers seek out healthier drinks like sparkling water.
Shares of Aurora were up over 6 percent on the news Monday morning, as were other pot stocks like Tilray.
With a merger this big, creators, studios, and theaters all face uncertain futures. Here’s what experts are worried about and what good could come from it.
With disengagement rising and hybrid work shifting, 'Everybody Matters' author Bob Chapman explains why treating people well could define the future of work.
We sat down with Ali Furman, U.S. Consumer Markets Industry Leader at consulting firm PwC to ask what trends she garnered from the initial data this year.
Seth Schachner breaks down Zootopia 2’s record-smashing debut, holiday box office trends, early 2026 Oscar contenders, and what’s next for Netflix and WBD.
Truist's Mike Skordeles unpacks earnings trends, market correction, labor force dynamics, and what a possible December rate cut could mean for all of us.
